日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer

STRATEGIC-1:一项针对不可切除的 RAS/BRAF 野生型转移性结直肠癌的多线、随机、开放标签的 GERCOR-PRODIGE-39 III 期试验

Chibaudel, Benoist; Dourthe, Louis-Marie; André, Thierry; Henriques, Julie; Bourgeois, Vincent; Etienne, Pierre-Luc; Desramé, Jérôme; Carola, Elisabeth; Dupuis, Olivier; Baba-Hamed, Nabil; Auby, Dominique; Louvet, Christophe; Maillard, Emmanuel; Romano, Olivier; Tournigand, Christophe; Garcia-Larnicol, Marie-Line; Shacham-Shmueli, Einat; Bird, Brian Healey; Ghiringhelli, François; de Gramont, Aimery

Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials

对 III 期结肠癌患者循环肿瘤 DNA 和免疫评分的联合分析:PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece 试验的事后分析

Taieb, Julien; Souglakos, John; Boukovinas, Ioannis; Falcoz, Antoine; Pages, Franck; Messaritakis, Ippokratis; Bennouna, Jaafar; Artru, Pascal; Louvet, Christophe; Lepere, Celine; Emile, Jean Francois; Bouche, Olivier; Mazard, Thibault; Vernerey, Dewi; Vogiatzoglou, Konstantinos; Tzardi, Maria; Sharma, Shruti; Liu, Minetta C; Sethi, Himanshu; André, Thierry; Galon, Jérome; Laurent-Puig, Pierre

Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials

基于PETACC-8和IDEA-France试验中III期结肠癌肿瘤微环境和细胞周期转录组特征的预后模型

Gallois, Claire; Sroussi, Marine; André, Thierry; Mouillet-Richard, Sophie; Agueeff, Natacha; Mulot, Claire; Vernerey, Dewi; Louvet, Christophe; Bachet, Jean-Baptiste; Dourthe, Louis-Marie; Mazard, Thibault; Jary, Marine; Coutzac, Clélia; Lecaille, Cédric; Tabernero, Josep; Van Laethem, Jean-Luc; Lepage, Côme; Emile, Jean-François; de Reyniès, Aurélien; Taieb, Julien; Laurent-Puig, Pierre

The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors

METACER 全国性队列研究前瞻性地确定了胃肠道癌症脑转移的预后因素

Randrian, Violaine; Portales, Fabienne; Bouché, Olivier; Thezenas, Simon; Chibaudel, Benoist; Mabro, May; Terrebonne, Eric; Garnier-Tixidre, Claire; Louvet, Christophe; André, Thierry; Aparicio, Thomas; Dubreuil, Olivier; Bouché, Gregoire; Ychou, Marc; Tougeron, David

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma.

循环肿瘤DNA能够很好地预测晚期胃食管腺癌患者接受化疗联合免疫检查点抑制剂治疗的疗效

Tougeron David, Louvet Christophe, Desramé Jérôme, Evesque Ludovic, Angelergues Antoine, Carnot Aurélien, Breysacher Gilles, Zaanan Aziz, Etchepare Nicolas, Mabro May, Kaluzinski Laure, Petorin Caroline, Chibaudel Benoist, Aparicio Thomas, Bodere Anaïs, Rinaldi Yves, Le Malicot Karine, Emile Jean-François, Lepage Côme, Baures Aurélia, Djamai Hanane, Taly Valérie, Laurent-Puig Pierre

FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial

FOLFIRI联合度伐利尤单抗(加或不加曲美利木单抗)二线治疗晚期胃癌或胃食管交界处腺癌:PRODIGE 59-FFCD 1707-DURIGAST随机临床试验

Tougeron, David; Dahan, Laetitia; Evesque, Ludovic; Le Malicot, Karine; El Hajbi, Farid; Aparicio, Thomas; Bouché, Olivier; Bonichon Lamichhane, Nathalie; Chibaudel, Benoist; Angelergues, Antoine; Bodere, Anaïs; Phelip, Jean-Marc; Mabro, May; Kaluzinski, Laure; Petorin, Caroline; Breysacher, Gilles; Rinaldi, Yves; Zaanan, Aziz; Smith, Denis; Gouttebel, Marie-Claude; Perret, Clément; Etchepare, Nicolas; Emile, Jean-François; Sanfourche, Ivan; Di Fiore, Frédéric; Lepage, Côme; Artru, Pascal; Louvet, Christophe

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study

新辅助纳武利尤单抗联合伊匹木单抗及辅助纳武利尤单抗治疗局部错配修复缺陷/微卫星不稳定性高表达的胃或食管胃交界处腺癌:GERCOR NEONIPIGA II期研究

André, Thierry; Tougeron, David; Piessen, Guillaume; de la Fouchardière, Christelle; Louvet, Christophe; Adenis, Antoine; Jary, Marine; Tournigand, Christophe; Aparicio, Thomas; Desrame, Jérôme; Lièvre, Astrid; Garcia-Larnicol, Marie-Line; Pudlarz, Thomas; Cohen, Romain; Memmi, Salomé; Vernerey, Dewi; Henriques, Julie; Lefevre, Jérémie H; Svrcek, Magali

Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study

瑞戈非尼及其主要代谢物M-2和M-5谷浓度对化疗难治性转移性结直肠癌患者总生存期的影响:一项多中心GERCOR TEXCAN II期研究的结果

Rousseau, Benoit; Boukerma, Arezki K; Henriques, Julie; Cohen, Romain; Lucidarme, Olivier; Borg, Christophe; Tournigand, Christophe; Kim, Stefano; Bachet, Jean-Baptiste; Mazard, Thibault; Louvet, Christophe; Chibaudel, Benoist; Vernerey, Dewi; Andre, Thierry; Hulin, Anne

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

严重急性呼吸综合征冠状病毒 2 疫苗接种在实体瘤患者中的应用:法国肿瘤学跨组研究组(GCO、TNCD、UNICANCER)的综述和观点

Tougeron, David; Hentzien, Maxime; Seitz-Polski, Barbara; Bani-Sadr, Firouze; Bourhis, Jean; Ducreux, Michel; Gaujoux, Sébastien; Gorphe, Philippe; Guiu, Boris; Hoang-Xuan, Khê; Huguet, Florence; Lecomte, Thierry; Lièvre, Astrid; Louvet, Christophe; Maggiori, Léon; Mansi, Laura; Mariani, Pascale; Michel, Pierre; Servettaz, Amélie; Thariat, Juliette; Westeel, Virgine; Aparicio, Thomas; Blay, Jean-Yves; Bouché, Olivier

Monitoring levels of circulating cell-free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment

监测转移性结直肠癌患者循环游离DNA水平,作为瑞戈非尼治疗反应的潜在生物标志物

Pastor, Brice; André, Thierry; Henriques, Julie; Trouilloud, Isabelle; Tournigand, Christophe; Jary, Marine; Mazard, Thibault; Louvet, Christophe; Azan, Simon; Bauer, Audrey; Roch, Benoit; Sanchez, Cynthia; Vernerey, Dewi; Thierry, Alain R; Adenis, Antoine